Log in

MediciNova News Headlines (NASDAQ:MNOV)

$3.28
-0.10 (-2.96 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$3.10
Now: $3.28
$3.49
50-Day Range
$2.90
MA: $4.53
$6.16
52-Week Range
$2.79
Now: $3.28
$13.37
Volume206,800 shs
Average Volume182,131 shs
Market Capitalization$144.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.64

Headlines

MediciNova (NASDAQ MNOV) News Headlines

Source:
DateHeadline
 MediciNova, Inc. (NASDAQ:MNOV) Receives Average Recommendation of "Strong Buy" from Analysts MediciNova, Inc. (NASDAQ:MNOV) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - March 25 at 12:12 AM
MediciNova IncMediciNova Inc
www.bloomberg.com - March 21 at 10:42 PM
MediciNova (NASDAQ:MNOV) PT Lowered to $11.00 at B. RileyMediciNova (NASDAQ:MNOV) PT Lowered to $11.00 at B. Riley
www.americanbankingnews.com - March 13 at 10:54 PM
Yuichi Iwaki Buys 20,000 Shares of MediciNova, Inc. (NASDAQ:MNOV) StockYuichi Iwaki Buys 20,000 Shares of MediciNova, Inc. (NASDAQ:MNOV) Stock
www.americanbankingnews.com - March 12 at 9:18 PM
MNOV: MN-166 to be Developed as a Treatment for Severe Pneumonia and Acute Respiratory Distress Syndrome…MNOV: MN-166 to be Developed as a Treatment for Severe Pneumonia and Acute Respiratory Distress Syndrome…
finance.yahoo.com - March 12 at 3:11 PM
MediciNova expands development of lead candidate into respiratory failureMediciNova expands development of lead candidate into respiratory failure
seekingalpha.com - March 10 at 8:06 AM
Should You Be Concerned About MediciNova, Inc.'s (NASDAQ:MNOV) Historical Volatility?Should You Be Concerned About MediciNova, Inc.'s (NASDAQ:MNOV) Historical Volatility?
finance.yahoo.com - February 27 at 12:25 PM
MNOV: Multiple Trials of MN-166 Ongoing; Recent Price Move Creates Buying OpportunityMNOV: Multiple Trials of MN-166 Ongoing; Recent Price Move Creates Buying Opportunity
finance.yahoo.com - February 25 at 5:21 PM
MediciNova nabs patent in Japan in NASHMediciNova nabs patent in Japan in NASH
seekingalpha.com - February 18 at 12:33 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in JapanMediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan
feeds.benzinga.com - February 17 at 7:13 PM
MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in EuropeMediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
feeds.benzinga.com - January 27 at 6:53 PM
MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine DependenceMediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence
www.bloomberg.com - December 31 at 8:52 PM
MediciNova Announces Additional Analyses from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 30th International Symposium on ALS/MND in Perth, AustraliaMediciNova Announces Additional Analyses from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 30th International Symposium on ALS/MND in Perth, Australia
finance.yahoo.com - December 4 at 6:39 PM
Were Not Worried About MediciNovas (NASDAQ:MNOV) Cash BurnWe're Not Worried About MediciNova's (NASDAQ:MNOV) Cash Burn
finance.yahoo.com - November 18 at 5:52 PM
We're Not Worried About MediciNova's (NASDAQ:MNOV) Cash BurnWe're Not Worried About MediciNova's (NASDAQ:MNOV) Cash Burn
finance.yahoo.com - November 18 at 5:52 PM
Here is What Hedge Funds Think About MediciNova, Inc. (MNOV)Here is What Hedge Funds Think About MediciNova, Inc. (MNOV)
finance.yahoo.com - November 6 at 2:48 PM
MNOV: Phase 3 Trial Initiated for MN-166 in ALSMNOV: Phase 3 Trial Initiated for MN-166 in ALS
finance.yahoo.com - October 31 at 12:59 PM
MediciNova nabs new Canadian patent covering ibudilastMediciNova nabs new Canadian patent covering ibudilast
seekingalpha.com - October 28 at 8:31 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in CanadaMediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
finance.yahoo.com - October 28 at 8:31 AM
MediciNova nabs new patent in Japan for MN-001MediciNova nabs new patent in Japan for MN-001
seekingalpha.com - October 23 at 8:48 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in JapanMediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan
www.benzinga.com - October 23 at 6:43 AM
MediciNova nabs new patent for MN-001 and MN-002 in JapanMediciNova nabs new patent for MN-001 and MN-002 in Japan
seekingalpha.com - October 8 at 8:34 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in JapanMediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan
finance.yahoo.com - October 7 at 11:13 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in ChinaMediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China
finance.yahoo.com - September 30 at 10:09 PM
Medicinova Inc Common Stock (MNOV) Analyst ResearchMedicinova Inc Common Stock (MNOV) Analyst Research
www.nasdaq.com - September 27 at 11:58 PM
Does Market Volatility Impact MediciNova, Inc.'s (NASDAQ:MNOV) Share Price?Does Market Volatility Impact MediciNova, Inc.'s (NASDAQ:MNOV) Share Price?
finance.yahoo.com - September 19 at 6:48 PM
MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New YorkMediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York
finance.yahoo.com - September 11 at 7:35 PM
MediciNova: Leading The Pack In An MS SubtypeMediciNova: Leading The Pack In An MS Subtype
seekingalpha.com - August 20 at 11:17 PM
MNOV: Abstract on MN-166 to be Presented at ALS/MND International Symposium…MNOV: Abstract on MN-166 to be Presented at ALS/MND International Symposium…
finance.yahoo.com - August 14 at 5:57 PM
MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in JapanMediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in Japan
finance.yahoo.com - July 30 at 10:58 PM
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, AustraliaMediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia
finance.yahoo.com - July 29 at 11:46 PM
MediciNova Appoints Kazuko Matsuda to its Board of DirectorsMediciNova Appoints Kazuko Matsuda to its Board of Directors
finance.yahoo.com - July 24 at 11:02 PM
MediciNova, Inc. (MNOV)MediciNova, Inc. (MNOV)
uk.finance.yahoo.com - July 24 at 10:30 AM
What Type Of Shareholder Owns MediciNova, Inc.'s (NASDAQ:MNOV)?What Type Of Shareholder Owns MediciNova, Inc.'s (NASDAQ:MNOV)?
finance.yahoo.com - July 18 at 5:24 PM
MNOV: Readying for Phase 3 Trial in Multiple Sclerosis…MNOV: Readying for Phase 3 Trial in Multiple Sclerosis…
finance.yahoo.com - July 18 at 5:24 PM
MediciNova readies late-stage study of MN-166 in progressive MSMediciNova readies late-stage study of MN-166 in progressive MS
seekingalpha.com - July 12 at 9:40 AM
MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MSMediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS
finance.yahoo.com - July 12 at 9:40 AM
MediciNova And Tipelukast In NASH, And The Market AssessmentMediciNova And Tipelukast In NASH, And The Market Assessment
seekingalpha.com - June 17 at 10:51 AM
MediciNova to Present at the JMP Securities Life Sciences ConferenceMediciNova to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 12 at 7:51 PM
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALSMediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS
finance.yahoo.com - June 6 at 9:55 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Certain Officers and Directors of MediciNova, Inc.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Certain Officers and Directors of MediciNova, Inc.
finance.yahoo.com - May 16 at 6:14 PM
MNOV: Plans in Place for Phase 3 Trial in ALS…MNOV: Plans in Place for Phase 3 Trial in ALS…
finance.yahoo.com - May 9 at 6:08 PM
MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United KingdomMediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United Kingdom
finance.yahoo.com - May 8 at 9:43 AM
If You Had Bought MediciNova (NASDAQ:MNOV) Stock Five Years Ago, You Could Pocket A 536% Gain TodayIf You Had Bought MediciNova (NASDAQ:MNOV) Stock Five Years Ago, You Could Pocket A 536% Gain Today
finance.yahoo.com - May 8 at 9:43 AM
MediciNova nabs new U.S. patent for MN-166MediciNova nabs new U.S. patent for MN-166
seekingalpha.com - April 24 at 9:47 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of GlioblastomaMediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
finance.yahoo.com - April 24 at 9:47 AM
MediciNova on go with pivotal study of MN-166 in ALSMediciNova on go with pivotal study of MN-166 in ALS
seekingalpha.com - April 16 at 10:42 AM
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALSMediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
finance.yahoo.com - April 16 at 10:42 AM
MNOV: New Analysis Shows Efficacy of MN-166 in Non-Relapsing SPMS…MNOV: New Analysis Shows Efficacy of MN-166 in Non-Relapsing SPMS…
finance.yahoo.com - April 8 at 12:24 PM
MediciNova nabs new patent in ChinaMediciNova nabs new patent in China
seekingalpha.com - April 4 at 9:51 AM
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel